Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EGFR-activating mutations are not present in breast tumors of Japanese patients.

Anticancer research - 1 Oct 2010

Uramoto Hidetaka, Shimokawa Hidehiko, Nagata Yoshika, Ono Kenji, Hanagiri Takeshi

Abstract excerpt

BACKGROUND: Despite advances in treatment, recurrent breast cancer remains a lethal disease. The epidermal growth factor receptor family has been suggested to play a role in breast cancer. However, no investigations of the frequency of EGFR mutation and the potential role of EGFR tyrosine kinase...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Enzyme Activation

Share to ErbB Receptors

Share to EGFR gene

Share to Mutation

Source

Identifiers

PMID: 21036744

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-21036744-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EGFR-activating mutations are not present in breast tumors of Japanese patients.PMID 21036744Read ↗

Lack of epidermal growth factor receptor (EGFR)-activating mutations in triple-negative breast cancer in China.Semantic proximity Read ↗

Absence of evidence for epidermal growth factor receptor and human homolog of the Kirsten rat sarcoma-2 virus oncogene mutations in breast cancer.Semantic proximity Read ↗

EGFR mRNA is upregulated, but somatic mutations of the gene are hardly found in renal cell carcinoma in Japanese patients.Semantic proximity Read ↗

EGFR and erbB2 mutation status in Japanese lung cancer patientsSemantic proximity Read ↗

Analysis of ERBB4 mutations and expression in japanese patients with lung cancer.Semantic proximity Read ↗

Mutational analysis of key EGFR pathway genes in Chinese breast cancer patients.Semantic proximity Read ↗

Lack of EGFR-activating mutations in European patients with triple-negative breast cancer could emphasise geographic and ethnic variations in breast cancer mutation profiles.Semantic proximity Read ↗

EGFR Mutation status in Japanese lung cancer patients: genotyping analysis using LightCycler.Semantic proximity Read ↗

Correlation between epidermal growth factor receptor mutations and expression of female hormone receptors in East-Asian lung adenocarcinomas.Semantic proximity Read ↗

The epidermal growth factor receptor (EGFR / HER-1) gatekeeper mutation T790M is present in European patients with early breast cancer.Semantic proximity Read ↗

Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma.Semantic proximity Read ↗

EGFR and EGFRvIII expression in primary breast cancer and cell lines.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.